Company Analysis

DataMeds AI, Inc. (MEDS)

Nasdaq: MEDS · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Tampa, FL · filing with the SEC since 2024
Grade3.1
◀ Past 2.7● Present 2.7▶ Future 4.1
4 est.

The company now

DataMeds AI, Inc. is classed by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries (industry code 5122), based in Tampa, FL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $23 million and a loss of $101 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

Where the revenue comes from

fiscal 2025, as filed

Revenue by product, fiscal 2025

ProductFiscal 2025Fiscal 2024Share of revenue
Product$21.9M$17.7M93.7%
Pharmacy Retail Sales$865,695$352,3633.7%
Third Party Logistics Services$603,417$107,0002.6%

As tagged in its annual report (Form 10-K, filed Mar 20, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.

The desk's written account of this company, its Past, Present and Future, is not on file yet.

How the company works

The desk has not read this company's annual report yet.

The record in brief

The desk has not written this company's report yet.

SI Assistanton MEDS · research, not advice